Interv Akut Kardiol. 2013;12(1):8-11

Hemodynamic and echocardiographic changes in patients with liver cirrhosis treated

Radek Pudil1, Rudolf Praus1, Petr Hůlek2, Václav Šafka2, Tomáš Fejfar2, Martina Vašatová3, Jan Vojáček1
1 I. interní kardioangilogická klinika LF UK a FN, Hradec Králové
2 II. interní gastroenterologická klinika LF UK a FN, Hradec Králové
3 Ústav klinické biochemie a diagnostiky LF UK a FN, Hadec Králové

with transjugular intrahepatic portosystemic shunt

Purpose: Liver cirrhosis is associated with hyperdynamic circulation which can result in heart failure. Transjugular intrahepatic portosystemic

shunt (TIPS) due to increase of cardiac output is a stressful stimulus for cardiovascular system. Therefore, new methods for early

detection of heart failure are needed. The aim of the study was to analyze the effect of TIPS procedure on hemodynamic.

Material and Methods: 55 patients (38 men and 17 women, 55.6 ± 8.9 years) with liver cirrhosis treated with TIPS were enrolled in the

study. Echocardiography was performed before, 24 hours, 7, 30 and 180 days after the procedure.

Results: Left ventricular end-diastolic diameter (LVEDD) was increasing [before: median 47 (interquartile range: 44.7–51.2) mm, day 7: 50

(46.5–51.3) mm, p < 0.05; day 30: 49.5 (46.7–55.2) mm, p < 0.01; day 180: 52.5 (48.3–55.2) mm, p < 0.01)]. We noticed increase in vena cava

inferior (VCI) diameter [before: 17 (15.5–19) mm, 24 h: 17 (15.5–19), p ns; day 7: 18 (16.3–19.4), p ns; day 30: 18.7 (16.5–19.8) mm, p < 0.05; day 180:

19 (18.2–20.5), p < 0.05]. Right ventricular (RV) diameter was increasing [before: 27 (25–29) mm, 24 h: 28 (26–30) mm, p ns; day 7: 29 (27.5–30)

mm, p < 0.05; day 30: 30 (27–31) mm, p < 0.05; day 180: 30 (27.5–31.2), p < 0.05]. Transmitral E wave significantly was increasing [before: 75,5

(60.5–87.3) cm/s, 24 h: 88 (74.3–109.7), p < 0.01; day 7: 89 (81.5–105) p < 0.01; 1 month: 94 (82.7–108.5) p < 0.01; 6 months: 91 (80.1–120.2) p

< 0.01]. The E/A ratio was increasing during the follow up (baseline: 0.88, 24 h after: 0.89, 1 week: 1.0, 30 days: 1.13, 6 month: 1.06 p < 0.01).

Conclusion: Hemodynamic changes following TIPS procedure can be monitored using echocardiography. Transmitral flow analysis can

serve as a useful tool for evaluating of diastolic function in these patients.

Keywords: liver cirrhosis, transjugular portosystemic shunt, hemodynamics, echocardiography

Published: February 21, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pudil R, Praus R, Hůlek P, Šafka V, Fejfar T, Vašatová M, Vojáček J. Hemodynamic and echocardiographic changes in patients with liver cirrhosis treated. Interv Akut Kardiol. 2013;12(1):8-11.
Download citation

References

  1. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362(25): 2370-2379. Go to original source... Go to PubMed...
  2. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 51(1): 306. Go to original source... Go to PubMed...
  3. Huonker M, Schumacher YO, Soricher S, Keul J, Rossle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999; 44: 743-748. Go to original source... Go to PubMed...
  4. Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999; 29: 632-639. Go to original source... Go to PubMed...
  5. Merli M, Valeriano V, Funaro S, Attili AF, Masini A, Efrati C, De CS, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002; 97: 142-148. Go to original source... Go to PubMed...
  6. Montgomery A, Ferral H, Vasan R, Postoak DW. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 2005; 28(3): 307-12. Go to original source... Go to PubMed...
  7. Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999; 97: 259-267. Go to original source...
  8. M?ller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008; 57: 268-278. Go to original source... Go to PubMed...
  9. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, M?ller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002; 36: 513-520. Go to original source... Go to PubMed...
  10. Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996; 31: 279-284. Go to original source... Go to PubMed...
  11. Umgelter A, Reindl W, Geisler F, Saugel B, Huber W, Berger H, Schmid RM. Effects of TIPS on global end-diastolic volume and cardiac output and renal resistive index in ICU patients with advanced alcoholic cirrhosis. Ann Hepatol 2010; 9(1): 40-45. Go to original source... Go to PubMed...
  12. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I. Diagnosis, prognosis and measurements of diastolic function. Circulation 2002;105: 1387-1393. Go to original source... Go to PubMed...
  13. Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med 2004; 351: 1097-1105. Go to original source... Go to PubMed...
  14. Little WC, Kitzman DW, Cheng CP. Diastolic dysfunction as a cause of exercise intolerance. Heart Fail Rev 2000; 5: 301-306. Go to original source... Go to PubMed...
  15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J Am Soc Echocardiogr 2009; 22(2): 107-133. Go to original source... Go to PubMed...
  16. Ortiz-Olvera NX, Castellanos-Pallares G, Gómez-Jiménez LM, Cabrera-Mu?oz ML, Méndez-Navarro J, Morán-Villota S, Dehesa-Violante M. Anatomical cardiac alterations in liver cirrhosis: An autopsy study. Ann Hepatol. 2011; 10(3): 321-326. Go to original source... Go to PubMed...
  17. Blendis L, Wong F. Is there a cirrhotic cardiomyopathy? Am J Gastroenterol 2000; 11: 3026-3028. Go to original source... Go to PubMed...
  18. Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, et al. Evidence of structural and functional cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131-1137. Go to original source... Go to PubMed...
  19. Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut 2007; 56: 869-875. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.